Cost-effectiveness analysis of insulin detemir compared to NPH insulin in patients with type-2 diabetes in the United Kingdom

被引：2
|
作者：
Smith, I
Palmer, AJ
Roze, S
Kennedy-Martin, T
机构：
[1] Novo Nordisk UK, Crawley, England
[2] CORE Ctr Outcomes Res, Basel, Switzerland
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65946-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：735 / 736
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis
    Tunis, Sandra L.
    Minshall, Michael E.
    Conner, Christopher
    McCormick, John I.
    Kapor, Jovana
    Yale, Jean-Francois
    Groleau, Danielle
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (05) : 1273 - 1284
  • [2] Cost-effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Portugal
    Cardoso, Cristina
    Ramirez de Arellano, Antonio
    Prades, Miriam
    Lizan, Luis
    [J]. JOURNAL OF DIABETES & METABOLISM, 2016, 7 (03)
  • [3] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Morales, Cristobal
    de Luis, Daniel
    Ramirez de Arellano, Antonio
    Giovanna Ferrario, Maria
    Lizan, Luis
    [J]. DIABETES THERAPY, 2015, 6 (04) : 593 - 610
  • [4] COST SAVINGS IN TYPE-2 DIABETES (T2D) WITH INSULIN GLARGINE COMPARED WITH INSULIN DETEMIR IN THE UNITED KINGDOM
    Tilling, C.
    Evans, L. M.
    Keech, M.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A96 - A96
  • [5] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Cristóbal Morales
    Daniel de Luis
    Antonio Ramírez de Arellano
    Maria Giovanna Ferrario
    Luis Lizán
    [J]. Diabetes Therapy, 2015, 6 : 593 - 610
  • [6] SHORT-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH INSULIN IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES IN SWEDEN
    Ridderstrale, M.
    Ericsson, A.
    Jensen, M. M.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A480 - A480
  • [7] SHORT-TERM COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR VERSUS INSULIN NEUTRAL PROTAMINE HAGEDORN (NPH) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN SPAIN
    Ramirez de Arellano, A.
    Morales, C.
    De Luis, D.
    Ferrario, M. G.
    Lizan, L.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A343 - A343
  • [8] COST-EFFECTIVENESS OF INSULIN DETEMIR IN PEOPLE WITH TYPE 2 DIABETES IN ROMANIA
    Ionescu-Targoviste, C.
    Wrona, W.
    Schubert, A.
    Niewada, M.
    Czech, M.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A500 - A500
  • [9] An analysis of the cost-effectiveness of starting insulin detemir in insulin-naive people with type 2 diabetes
    Home, Philip
    Baik, Sei Hyun
    Gonzalez Galvez, Guillermo
    Malek, Rachid
    Nikolajsen, Annie
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (03) : 230 - 240
  • [10] Cost-effectiveness of insulin detemir versus NPH for type I diabetes patients in an Italian setting. A meta-analysis
    Aristides, M.
    Kotchie, R.
    Nielsen, S.
    Aagren, M.
    Valentine, W. J.
    Goodall, G.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A260 - A260
12345